Expression and purification of recombinant human serum albumin fusion protein with VEGF165b in Pichia pastoris

  • Zhu R
  • Xin X
  • Dai H
 et al. 
  • 2


    Mendeley users who have this article in their library.
  • N/A


    Citations of this article.


VEGF165b is an endogenous transcriptional splice variant of VEGF and has been shown to have a therapeutic potency as an anti-cancer agent. In this report, a fusion gene consisting of a human VEGF165b and a human albumin (HSA) gene was constructed and then inserted into a pPIC9k vector. The recombinant fusion protein, rhHSA-VEGF165b, was over expressed in the methylotrophic yeast Pichia pastoris under the control of AOX1 promoter. After induction with methanol, the expression level of rhHSA-VEGF165b was 275mg/L in broth. The fusion protein rhHSA-VEGF165b was purified to more than 95% purity by using Blue Sepharose Fast Flow and SP Sepharose Fast Flow. Biological activity of the prepared rhHSA-VEGF165b was characterized by transwell migration assay, retaining about 9% of that of unmodified rhVEGF165b on a molar basis. Data from mice show that the serum half-life time of rhHSA-VEGF165b was nearly 20 times longer than that of rhVEGF165b

Author-supplied keywords

  • VEGF
  • VEGF165b
  • albumin
  • endogenous
  • expression
  • fusion
  • induction
  • migration
  • pichia
  • promoter
  • protein
  • purification
  • vector
  • yeast

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

  • PMID: 22750397


  • R Y Zhu

  • X Xin

  • H Y Dai

  • Q Li

  • J Y Lei

  • Y Chen

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free